Literature DB >> 18941866

Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome.

Nana Sasaki1, Junya Kuroda2, Eri Kawata3, Teruaki Akaogi3, Miki Kiyota3, Yutaka Kobayashi3, Masafumi Taniwaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18941866     DOI： 10.1007/s12185-008-0180-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

Review 1.  Management of thrombotic thrombocytopenic purpura.

Authors:  G A Rock
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

2.  Pathologic quiz case: a 20-year-old man with a history of hemoptysis and purpura.

Authors:  I Doudenko-Pirozzolo; R Booth
Journal:  Arch Pathol Lab Med       Date:  2001-06       Impact factor: 5.534

Review 3.  Treatment of thrombotic thrombocytopenic purpura.

Authors:  S Fontana; J A Kremer Hovinga; B Lämmle; B Mansouri Taleghani
Journal:  Vox Sang       Date:  2006-05       Impact factor: 2.144

4.  Acute onset of juvenile myelodysplastic syndrome mimicking thrombotic thrombocytopenic purpura and rapidly evolving in overt myeloid leukemia.

Authors:  G Leone; S Sica; V De Stefano; L Teofili; L M Larocca; G D'Onofrio; M Zollino
Journal:  Am J Hematol       Date:  1992-09       Impact factor: 10.047

5.  Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.

Authors:  Dragomir Marisavljević; Nada Kraguljac; Zoran Rolović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

6.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

7.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.

Authors:  M Furlan; R Robles; M Solenthaler; M Wassmer; P Sandoz; B Lämmle
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

Review 9.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245
View more
  2 in total

1.  Pancytopenia and TTP-like picture secondary to pernicious anaemia.

Authors:  Peiting Chen; Preethi Ramachandran; Karan Josan; Jen Chin Wang
Journal:  BMJ Case Rep       Date:  2020-07-05

2.  Myelodysplastic Syndrome Clinically Presenting with the "Classic TTP Pentad".

Authors:  Santiago Fabián Moscoso Martínez; Evelyn Carolina Polanco Jácome; Elizabeth Guevara; Vijay Mattoo
Journal:  Case Rep Hematol       Date:  2017-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.